Novel anticancer strategy targets DNA repair.
Opar
Alisa
A
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D017322:Clinical Trials, Phase II as Topic / Q000639:trends; D004260:DNA Repair / Q000187:drug effects* / Q000235:genetics; D015507:Drugs, Investigational / Q000008:administration & dosage*; D018390:Gene Targeting / Q000379:methods / Q000639:trends; D006801:Humans; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism
D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011065:Poly(ADP-ribose) Polymerases